Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Adrenoleukodystrophy | 45 | 2024 | 143 | 17.820 |
Why?
|
Leukodystrophy, Metachromatic | 12 | 2024 | 44 | 3.750 |
Why?
|
Hereditary Sensory and Autonomic Neuropathies | 7 | 2024 | 41 | 2.150 |
Why?
|
Sphingolipids | 10 | 2024 | 174 | 1.990 |
Why?
|
Serine C-Palmitoyltransferase | 9 | 2024 | 42 | 1.720 |
Why?
|
ATP-Binding Cassette Transporters | 6 | 2023 | 563 | 1.640 |
Why?
|
Cystinosis | 3 | 2022 | 26 | 1.580 |
Why?
|
Adrenal Insufficiency | 5 | 2023 | 194 | 1.560 |
Why?
|
Hereditary Central Nervous System Demyelinating Diseases | 6 | 2020 | 42 | 1.530 |
Why?
|
Genetic Vectors | 7 | 2024 | 3396 | 1.510 |
Why?
|
Gangliosidoses, GM2 | 6 | 2024 | 20 | 1.430 |
Why?
|
Lentivirus | 3 | 2024 | 508 | 1.430 |
Why?
|
Serine | 6 | 2022 | 831 | 1.160 |
Why?
|
Leukoencephalopathies | 5 | 2017 | 256 | 1.160 |
Why?
|
Hematopoietic Stem Cell Transplantation | 13 | 2024 | 5672 | 1.130 |
Why?
|
Dependovirus | 5 | 2022 | 718 | 1.070 |
Why?
|
Lysosomal Storage Diseases | 4 | 2022 | 79 | 1.070 |
Why?
|
Canavan Disease | 2 | 2024 | 6 | 1.010 |
Why?
|
Distal Myopathies | 2 | 2020 | 18 | 0.870 |
Why?
|
Cost of Illness | 4 | 2024 | 1937 | 0.850 |
Why?
|
Neurodegenerative Diseases | 4 | 2024 | 1088 | 0.850 |
Why?
|
Neonatal Screening | 8 | 2024 | 597 | 0.850 |
Why?
|
Demyelinating Diseases | 6 | 2017 | 352 | 0.830 |
Why?
|
Nerve Fibers, Myelinated | 4 | 2012 | 952 | 0.800 |
Why?
|
Sphingosine | 3 | 2019 | 308 | 0.770 |
Why?
|
Myelin Sheath | 3 | 2024 | 653 | 0.770 |
Why?
|
Xanthomatosis, Cerebrotendinous | 2 | 2018 | 9 | 0.770 |
Why?
|
Brain | 23 | 2024 | 27121 | 0.750 |
Why?
|
Diabetic Neuropathies | 2 | 2022 | 405 | 0.730 |
Why?
|
Nervous System Diseases | 2 | 2024 | 1667 | 0.720 |
Why?
|
Spinal Cord Diseases | 2 | 2021 | 292 | 0.720 |
Why?
|
Deglutition Disorders | 3 | 2022 | 625 | 0.710 |
Why?
|
Magnetic Resonance Imaging | 29 | 2024 | 36426 | 0.700 |
Why?
|
Vision Disorders | 2 | 2024 | 1088 | 0.680 |
Why?
|
Restless Legs Syndrome | 1 | 2022 | 233 | 0.630 |
Why?
|
Astrocytes | 2 | 2024 | 1346 | 0.620 |
Why?
|
Muscular Diseases | 2 | 2020 | 553 | 0.610 |
Why?
|
Chenodeoxycholic Acid | 1 | 2018 | 34 | 0.600 |
Why?
|
Neural Conduction | 3 | 2019 | 441 | 0.600 |
Why?
|
Disease Progression | 18 | 2024 | 13510 | 0.600 |
Why?
|
Blood-Brain Barrier | 3 | 2017 | 1027 | 0.600 |
Why?
|
Basal Ganglia Diseases | 1 | 2017 | 145 | 0.570 |
Why?
|
Urinary Tract | 1 | 2021 | 313 | 0.570 |
Why?
|
Eukaryotic Initiation Factor-2B | 1 | 2016 | 9 | 0.540 |
Why?
|
Child | 40 | 2024 | 80158 | 0.540 |
Why?
|
Aspartic Acid | 3 | 2024 | 576 | 0.540 |
Why?
|
Receptor, Macrophage Colony-Stimulating Factor | 1 | 2016 | 94 | 0.530 |
Why?
|
Visual Perception | 1 | 2024 | 1389 | 0.520 |
Why?
|
Fatty Acids | 8 | 2022 | 1808 | 0.510 |
Why?
|
Gene Transfer Techniques | 3 | 2021 | 1206 | 0.510 |
Why?
|
Age of Onset | 8 | 2024 | 3306 | 0.500 |
Why?
|
Neuroblastoma | 1 | 2023 | 1250 | 0.500 |
Why?
|
Humans | 119 | 2024 | 761596 | 0.490 |
Why?
|
Growth Cones | 1 | 2015 | 117 | 0.490 |
Why?
|
Microglia | 3 | 2017 | 1362 | 0.490 |
Why?
|
Magnetic Resonance Spectroscopy | 7 | 2016 | 3769 | 0.490 |
Why?
|
Ovarian Diseases | 1 | 2016 | 137 | 0.480 |
Why?
|
Developmental Disabilities | 6 | 2024 | 1509 | 0.480 |
Why?
|
Hematopoietic Stem Cells | 3 | 2024 | 3397 | 0.480 |
Why?
|
Leukodystrophy, Globoid Cell | 2 | 2011 | 38 | 0.470 |
Why?
|
Transduction, Genetic | 3 | 2021 | 903 | 0.470 |
Why?
|
Dystonia | 1 | 2017 | 370 | 0.460 |
Why?
|
Male | 67 | 2024 | 360846 | 0.460 |
Why?
|
Hyperglycemia | 1 | 2022 | 1376 | 0.450 |
Why?
|
Adolescent | 29 | 2024 | 88326 | 0.450 |
Why?
|
Neurotoxins | 2 | 2011 | 240 | 0.440 |
Why?
|
Tay-Sachs Disease | 4 | 2024 | 20 | 0.420 |
Why?
|
Nonlinear Dynamics | 1 | 2015 | 492 | 0.420 |
Why?
|
Brain Diseases | 8 | 2019 | 1546 | 0.420 |
Why?
|
Ganglia, Spinal | 1 | 2015 | 526 | 0.420 |
Why?
|
Mosaicism | 1 | 2016 | 475 | 0.410 |
Why?
|
Spastic Paraplegia, Hereditary | 3 | 2024 | 168 | 0.400 |
Why?
|
Adult | 44 | 2024 | 221210 | 0.400 |
Why?
|
Young Adult | 21 | 2024 | 59260 | 0.400 |
Why?
|
Mutation | 17 | 2024 | 30053 | 0.400 |
Why?
|
Membrane Transport Proteins | 1 | 2017 | 1035 | 0.390 |
Why?
|
Clinical Trials as Topic | 3 | 2024 | 8002 | 0.380 |
Why?
|
Amino Acid Metabolism, Inborn Errors | 3 | 2015 | 283 | 0.370 |
Why?
|
Microvessels | 1 | 2015 | 577 | 0.370 |
Why?
|
Child, Preschool | 20 | 2024 | 42232 | 0.350 |
Why?
|
Metabolic Diseases | 2 | 2018 | 683 | 0.350 |
Why?
|
Seizures | 3 | 2017 | 2957 | 0.350 |
Why?
|
Rare Diseases | 3 | 2024 | 622 | 0.350 |
Why?
|
Retrospective Studies | 17 | 2024 | 80647 | 0.340 |
Why?
|
Sulfite Oxidase | 2 | 2006 | 10 | 0.340 |
Why?
|
Cerebrovascular Circulation | 5 | 2017 | 2727 | 0.340 |
Why?
|
Brain Diseases, Metabolic, Inborn | 2 | 2006 | 46 | 0.330 |
Why?
|
Caregivers | 3 | 2022 | 2238 | 0.330 |
Why?
|
Infant, Newborn | 18 | 2024 | 26202 | 0.310 |
Why?
|
Severity of Illness Index | 9 | 2024 | 15843 | 0.310 |
Why?
|
Mutation, Missense | 4 | 2024 | 2571 | 0.310 |
Why?
|
Female | 51 | 2024 | 392705 | 0.310 |
Why?
|
Charcot-Marie-Tooth Disease | 2 | 2022 | 100 | 0.300 |
Why?
|
Animals | 24 | 2024 | 168475 | 0.290 |
Why?
|
Gliosis | 1 | 2008 | 245 | 0.280 |
Why?
|
Infant | 20 | 2024 | 36193 | 0.280 |
Why?
|
Protein Subunits | 2 | 2009 | 943 | 0.280 |
Why?
|
Sinus Thrombosis, Intracranial | 1 | 2007 | 110 | 0.270 |
Why?
|
Cerebroside-Sulfatase | 2 | 2024 | 15 | 0.270 |
Why?
|
Creatine | 4 | 2015 | 427 | 0.260 |
Why?
|
Mice | 15 | 2024 | 81539 | 0.260 |
Why?
|
Gene Expression | 4 | 2017 | 7581 | 0.260 |
Why?
|
Middle Aged | 27 | 2024 | 220921 | 0.260 |
Why?
|
Phenotype | 6 | 2021 | 16592 | 0.250 |
Why?
|
Family | 1 | 2016 | 3195 | 0.250 |
Why?
|
Treatment Outcome | 11 | 2024 | 64685 | 0.240 |
Why?
|
Metabolism, Inborn Errors | 2 | 2017 | 284 | 0.240 |
Why?
|
Neurons | 5 | 2023 | 9463 | 0.240 |
Why?
|
Nervous System Malformations | 2 | 2024 | 244 | 0.240 |
Why?
|
Encephalitis | 1 | 2008 | 440 | 0.230 |
Why?
|
Amidohydrolases | 2 | 2024 | 159 | 0.230 |
Why?
|
Diabetes Mellitus | 1 | 2022 | 5841 | 0.230 |
Why?
|
Lysophosphatidylcholines | 2 | 2017 | 77 | 0.220 |
Why?
|
Cholinergic Agents | 1 | 2023 | 96 | 0.220 |
Why?
|
Autoimmune Diseases of the Nervous System | 1 | 2024 | 75 | 0.220 |
Why?
|
Endothelium, Vascular | 1 | 2015 | 4431 | 0.220 |
Why?
|
Neurofilament Proteins | 2 | 2023 | 336 | 0.200 |
Why?
|
Disease Models, Animal | 5 | 2024 | 18255 | 0.200 |
Why?
|
Spinal Cord | 3 | 2021 | 1819 | 0.200 |
Why?
|
Herpesviridae | 1 | 2022 | 106 | 0.200 |
Why?
|
Heterozygote | 4 | 2015 | 2787 | 0.200 |
Why?
|
Peroxisomes | 1 | 2022 | 68 | 0.190 |
Why?
|
Nervous System | 1 | 2024 | 545 | 0.190 |
Why?
|
Skin | 1 | 2015 | 4484 | 0.190 |
Why?
|
Homozygote | 3 | 2016 | 1776 | 0.180 |
Why?
|
Alanine | 2 | 2015 | 609 | 0.180 |
Why?
|
Cause of Death | 1 | 2011 | 3683 | 0.180 |
Why?
|
Stearoyl-CoA Desaturase | 1 | 2021 | 85 | 0.180 |
Why?
|
Microcirculation | 2 | 2017 | 1272 | 0.180 |
Why?
|
RNA, Messenger | 1 | 2015 | 12794 | 0.180 |
Why?
|
Breathing Exercises | 1 | 2020 | 59 | 0.170 |
Why?
|
Cells, Cultured | 4 | 2017 | 18966 | 0.170 |
Why?
|
Corpus Callosum | 2 | 2019 | 751 | 0.170 |
Why?
|
Quality of Life | 5 | 2024 | 13367 | 0.170 |
Why?
|
Macula Lutea | 2 | 2019 | 177 | 0.170 |
Why?
|
Confusion | 1 | 2002 | 278 | 0.170 |
Why?
|
Prevalence | 4 | 2022 | 15733 | 0.170 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2014 | 3415 | 0.170 |
Why?
|
Chloroquine | 1 | 2021 | 274 | 0.170 |
Why?
|
Retinal Telangiectasis | 1 | 2019 | 25 | 0.170 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2024 | 858 | 0.160 |
Why?
|
Respiratory Aspiration | 1 | 2020 | 89 | 0.160 |
Why?
|
Spectrum Analysis | 1 | 2021 | 453 | 0.160 |
Why?
|
Brain Chemistry | 1 | 2002 | 960 | 0.160 |
Why?
|
Capsid | 1 | 2021 | 435 | 0.160 |
Why?
|
Consensus | 4 | 2024 | 3124 | 0.160 |
Why?
|
Choline | 3 | 2008 | 515 | 0.160 |
Why?
|
Carbon-Nitrogen Ligases | 1 | 2018 | 27 | 0.160 |
Why?
|
Early Diagnosis | 1 | 2023 | 1186 | 0.150 |
Why?
|
Multiple Sulfatase Deficiency Disease | 1 | 2018 | 2 | 0.150 |
Why?
|
Amino Acid Transport Systems, Acidic | 1 | 2018 | 30 | 0.150 |
Why?
|
Carbidopa | 1 | 2017 | 30 | 0.150 |
Why?
|
Follow-Up Studies | 7 | 2024 | 39106 | 0.150 |
Why?
|
Sulfatases | 1 | 2018 | 44 | 0.150 |
Why?
|
Patient Advocacy | 1 | 2020 | 360 | 0.150 |
Why?
|
Cerebral Amyloid Angiopathy | 1 | 2006 | 895 | 0.150 |
Why?
|
Injections, Spinal | 1 | 2018 | 318 | 0.150 |
Why?
|
Hyperalgesia | 1 | 2022 | 532 | 0.150 |
Why?
|
Phagocytosis | 2 | 2017 | 1528 | 0.150 |
Why?
|
Tandem Mass Spectrometry | 1 | 2024 | 1188 | 0.150 |
Why?
|
Myelodysplastic Syndromes | 2 | 2024 | 1394 | 0.150 |
Why?
|
Psychomotor Disorders | 1 | 2018 | 149 | 0.140 |
Why?
|
Brain Stem | 2 | 2019 | 858 | 0.140 |
Why?
|
Hand Strength | 1 | 2020 | 456 | 0.140 |
Why?
|
Ion Channels | 1 | 2022 | 1040 | 0.140 |
Why?
|
Aged | 14 | 2020 | 169310 | 0.140 |
Why?
|
Posture | 1 | 2001 | 957 | 0.140 |
Why?
|
Pan troglodytes | 1 | 2017 | 223 | 0.140 |
Why?
|
Milk Proteins | 1 | 2017 | 163 | 0.140 |
Why?
|
Levodopa | 1 | 2017 | 221 | 0.140 |
Why?
|
Antiporters | 1 | 2018 | 277 | 0.140 |
Why?
|
Cohort Studies | 7 | 2024 | 41495 | 0.140 |
Why?
|
Pilot Projects | 4 | 2022 | 8633 | 0.140 |
Why?
|
Biotin | 1 | 2017 | 253 | 0.140 |
Why?
|
Mice, Knockout | 4 | 2021 | 14417 | 0.140 |
Why?
|
Thiamine | 1 | 2017 | 160 | 0.140 |
Why?
|
Muscle Weakness | 1 | 2019 | 412 | 0.140 |
Why?
|
Nerve Degeneration | 1 | 2021 | 748 | 0.130 |
Why?
|
Eye Movements | 1 | 2020 | 511 | 0.130 |
Why?
|
Fibroblasts | 2 | 2018 | 4142 | 0.130 |
Why?
|
Neurologic Examination | 1 | 2019 | 916 | 0.130 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2021 | 1171 | 0.130 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2022 | 612 | 0.130 |
Why?
|
Amidinotransferases | 1 | 2015 | 11 | 0.130 |
Why?
|
Muscle Strength | 1 | 2020 | 624 | 0.130 |
Why?
|
Endpoint Determination | 1 | 2019 | 590 | 0.130 |
Why?
|
Mice, Transgenic | 3 | 2015 | 9542 | 0.130 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2019 | 455 | 0.130 |
Why?
|
Substrate Specificity | 3 | 2015 | 1791 | 0.130 |
Why?
|
Lipids | 4 | 2017 | 3341 | 0.130 |
Why?
|
Gait | 1 | 2021 | 814 | 0.120 |
Why?
|
Antigens, CD34 | 1 | 2017 | 658 | 0.120 |
Why?
|
Chimerism | 1 | 2016 | 155 | 0.120 |
Why?
|
Case-Control Studies | 4 | 2017 | 22176 | 0.120 |
Why?
|
Gadolinium | 1 | 2020 | 960 | 0.120 |
Why?
|
Protons | 2 | 2016 | 1116 | 0.120 |
Why?
|
Child Behavior | 1 | 2021 | 847 | 0.120 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2017 | 629 | 0.120 |
Why?
|
Respiratory Function Tests | 1 | 2019 | 1682 | 0.120 |
Why?
|
Zebrafish Proteins | 1 | 2021 | 1015 | 0.120 |
Why?
|
Fatty Acids, Monounsaturated | 1 | 2015 | 190 | 0.120 |
Why?
|
Survival Analysis | 3 | 2019 | 10090 | 0.120 |
Why?
|
Speech Disorders | 1 | 2015 | 180 | 0.120 |
Why?
|
Mitochondrial Diseases | 1 | 2018 | 343 | 0.120 |
Why?
|
Cerebral Hemorrhage | 1 | 2006 | 2656 | 0.120 |
Why?
|
Hand | 1 | 2019 | 903 | 0.110 |
Why?
|
Microcephaly | 1 | 2018 | 425 | 0.110 |
Why?
|
Optic Nerve | 1 | 2017 | 572 | 0.110 |
Why?
|
Sciatic Nerve | 2 | 2022 | 617 | 0.110 |
Why?
|
Extremities | 1 | 2019 | 867 | 0.110 |
Why?
|
Headache | 1 | 2002 | 1256 | 0.110 |
Why?
|
Cerebral Cortex | 4 | 2014 | 5779 | 0.110 |
Why?
|
Diagnosis, Differential | 7 | 2017 | 12973 | 0.110 |
Why?
|
Coculture Techniques | 1 | 2017 | 1341 | 0.110 |
Why?
|
Glutathione Peroxidase | 1 | 2015 | 258 | 0.110 |
Why?
|
Antigens, Surface | 1 | 2017 | 1606 | 0.110 |
Why?
|
Sandhoff Disease | 2 | 2024 | 14 | 0.110 |
Why?
|
Longitudinal Studies | 4 | 2024 | 14608 | 0.110 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2015 | 691 | 0.110 |
Why?
|
Repressor Proteins | 1 | 2024 | 2986 | 0.100 |
Why?
|
Combined Modality Therapy | 2 | 2017 | 8527 | 0.100 |
Why?
|
Hematologic Neoplasms | 1 | 2024 | 1896 | 0.100 |
Why?
|
Transplantation, Autologous | 1 | 2017 | 2115 | 0.100 |
Why?
|
Neuroglia | 2 | 2015 | 956 | 0.100 |
Why?
|
Depression, Chemical | 1 | 2011 | 184 | 0.100 |
Why?
|
Apoptosis | 1 | 2008 | 9490 | 0.100 |
Why?
|
Infant, Premature | 1 | 2001 | 2107 | 0.100 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2015 | 1126 | 0.100 |
Why?
|
Alcohol Oxidoreductases | 2 | 2012 | 169 | 0.100 |
Why?
|
Drug Combinations | 1 | 2017 | 2048 | 0.100 |
Why?
|
Analysis of Variance | 2 | 2015 | 6228 | 0.100 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2015 | 10766 | 0.100 |
Why?
|
Neuropsychological Tests | 1 | 2024 | 7054 | 0.100 |
Why?
|
Cross-Sectional Studies | 4 | 2024 | 26129 | 0.100 |
Why?
|
Receptors, Immunologic | 1 | 2017 | 1410 | 0.090 |
Why?
|
Adrenal Glands | 1 | 2013 | 552 | 0.090 |
Why?
|
Immunosuppressive Agents | 2 | 2015 | 4176 | 0.090 |
Why?
|
Gene Knockdown Techniques | 1 | 2015 | 1612 | 0.090 |
Why?
|
Genes, Reporter | 1 | 2015 | 1529 | 0.090 |
Why?
|
Stereoisomerism | 1 | 2011 | 614 | 0.090 |
Why?
|
Calcium-Binding Proteins | 1 | 2015 | 1069 | 0.090 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2014 | 12149 | 0.090 |
Why?
|
Galactosylceramidase | 1 | 2010 | 23 | 0.090 |
Why?
|
Testis | 1 | 2013 | 794 | 0.090 |
Why?
|
Cell Line, Tumor | 2 | 2018 | 16990 | 0.090 |
Why?
|
Microfilament Proteins | 1 | 2015 | 1134 | 0.090 |
Why?
|
Triplets | 1 | 2009 | 42 | 0.090 |
Why?
|
Hair | 1 | 2013 | 498 | 0.090 |
Why?
|
Pain Perception | 1 | 2011 | 196 | 0.090 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 1 | 2015 | 556 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2015 | 988 | 0.090 |
Why?
|
Anthracyclines | 1 | 2012 | 284 | 0.090 |
Why?
|
Psychometrics | 1 | 2019 | 3065 | 0.080 |
Why?
|
Dietary Supplements | 1 | 2022 | 3415 | 0.080 |
Why?
|
Age Factors | 2 | 2020 | 18399 | 0.080 |
Why?
|
Antibodies | 1 | 2017 | 2418 | 0.080 |
Why?
|
Microscopy, Confocal | 1 | 2015 | 1971 | 0.080 |
Why?
|
Acyl Coenzyme A | 1 | 2009 | 56 | 0.080 |
Why?
|
Sudden Infant Death | 2 | 2002 | 292 | 0.080 |
Why?
|
Protein Transport | 1 | 2015 | 1967 | 0.080 |
Why?
|
Prospective Studies | 3 | 2024 | 54423 | 0.080 |
Why?
|
Interviews as Topic | 1 | 2016 | 2696 | 0.080 |
Why?
|
Double-Blind Method | 2 | 2023 | 12341 | 0.080 |
Why?
|
Cerebellum | 2 | 2021 | 1501 | 0.080 |
Why?
|
Infertility, Male | 1 | 2011 | 395 | 0.080 |
Why?
|
Mice, Inbred C3H | 1 | 2009 | 915 | 0.080 |
Why?
|
Pain Measurement | 1 | 2019 | 3551 | 0.080 |
Why?
|
Psychotic Disorders | 1 | 2023 | 3223 | 0.080 |
Why?
|
Neuroanatomy | 1 | 2008 | 70 | 0.080 |
Why?
|
Image Enhancement | 1 | 2019 | 2884 | 0.080 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 4576 | 0.080 |
Why?
|
Neurology | 1 | 2016 | 780 | 0.080 |
Why?
|
DNA-Binding Proteins | 2 | 2015 | 9610 | 0.080 |
Why?
|
Movement Disorders | 1 | 2012 | 459 | 0.080 |
Why?
|
Polymerase Chain Reaction | 1 | 2017 | 6075 | 0.080 |
Why?
|
Periaqueductal Gray | 1 | 2008 | 110 | 0.080 |
Why?
|
Monitoring, Ambulatory | 2 | 2002 | 354 | 0.070 |
Why?
|
Self Report | 1 | 2019 | 3725 | 0.070 |
Why?
|
Inositol | 1 | 2008 | 215 | 0.070 |
Why?
|
Evaluation Studies as Topic | 2 | 2007 | 1625 | 0.070 |
Why?
|
Genetic Testing | 1 | 2020 | 3537 | 0.070 |
Why?
|
Pain | 1 | 2022 | 5073 | 0.070 |
Why?
|
Contrast Media | 1 | 2020 | 5307 | 0.070 |
Why?
|
Risk Assessment | 3 | 2023 | 23996 | 0.070 |
Why?
|
Leukoencephalopathy, Progressive Multifocal | 1 | 2008 | 133 | 0.070 |
Why?
|
Membrane Glycoproteins | 1 | 2017 | 3701 | 0.070 |
Why?
|
Point Mutation | 1 | 2011 | 1595 | 0.070 |
Why?
|
Up-Regulation | 1 | 2015 | 4125 | 0.070 |
Why?
|
Cyclophosphamide | 1 | 2012 | 2220 | 0.070 |
Why?
|
Cricetinae | 1 | 2009 | 2423 | 0.060 |
Why?
|
Data Collection | 1 | 2015 | 3322 | 0.060 |
Why?
|
Qualitative Research | 1 | 2016 | 3025 | 0.060 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2008 | 662 | 0.060 |
Why?
|
Pyramidal Tracts | 1 | 2007 | 252 | 0.060 |
Why?
|
Sex Factors | 2 | 2009 | 10554 | 0.060 |
Why?
|
Mice, Inbred C57BL | 3 | 2015 | 22174 | 0.060 |
Why?
|
Ribonuclease H | 1 | 2024 | 50 | 0.060 |
Why?
|
Brain Mapping | 2 | 2012 | 6635 | 0.060 |
Why?
|
Forkhead Transcription Factors | 1 | 2012 | 1616 | 0.060 |
Why?
|
Muscle, Skeletal | 1 | 2019 | 4948 | 0.060 |
Why?
|
Administration, Oral | 1 | 2011 | 4021 | 0.060 |
Why?
|
Psychomotor Performance | 1 | 2011 | 1882 | 0.050 |
Why?
|
Observer Variation | 1 | 2009 | 2606 | 0.050 |
Why?
|
Exodeoxyribonucleases | 1 | 2024 | 192 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7391 | 0.050 |
Why?
|
Antibody Formation | 1 | 2007 | 1395 | 0.050 |
Why?
|
Epilepsy | 1 | 2018 | 3290 | 0.050 |
Why?
|
Nerve Tissue Proteins | 1 | 2015 | 4415 | 0.050 |
Why?
|
Hypoxia-Ischemia, Brain | 1 | 2006 | 352 | 0.050 |
Why?
|
Barium | 1 | 2022 | 62 | 0.050 |
Why?
|
Endothelial Cells | 1 | 2015 | 3549 | 0.050 |
Why?
|
Oxidative Stress | 1 | 2013 | 3113 | 0.050 |
Why?
|
Stromal Cells | 1 | 2008 | 1330 | 0.050 |
Why?
|
Fatal Outcome | 3 | 2014 | 1835 | 0.050 |
Why?
|
Mammals | 2 | 2023 | 1132 | 0.050 |
Why?
|
France | 1 | 2023 | 497 | 0.050 |
Why?
|
Disability Evaluation | 1 | 2008 | 1836 | 0.050 |
Why?
|
Supine Position | 1 | 2001 | 205 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 1 | 2011 | 6484 | 0.050 |
Why?
|
Deglutition | 1 | 2022 | 208 | 0.050 |
Why?
|
Blood Flow Velocity | 2 | 2001 | 1371 | 0.040 |
Why?
|
Aged, 80 and over | 2 | 2016 | 58984 | 0.040 |
Why?
|
Prone Position | 1 | 2001 | 196 | 0.040 |
Why?
|
Intermediate Filaments | 1 | 2021 | 172 | 0.040 |
Why?
|
Chromatography, Liquid | 1 | 2024 | 983 | 0.040 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2021 | 168 | 0.040 |
Why?
|
Delphi Technique | 1 | 2024 | 846 | 0.040 |
Why?
|
Aging | 1 | 2019 | 8710 | 0.040 |
Why?
|
Ultrasonography, Doppler, Transcranial | 1 | 2001 | 281 | 0.040 |
Why?
|
Time Factors | 3 | 2011 | 39969 | 0.040 |
Why?
|
History, 21st Century | 1 | 2006 | 1567 | 0.040 |
Why?
|
Inflammation Mediators | 1 | 2008 | 1886 | 0.040 |
Why?
|
Macaca fascicularis | 1 | 2021 | 903 | 0.040 |
Why?
|
Echoencephalography | 1 | 1999 | 134 | 0.040 |
Why?
|
Delayed Diagnosis | 1 | 2023 | 463 | 0.040 |
Why?
|
Gene Deletion | 1 | 2006 | 2665 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 1998 | 11742 | 0.040 |
Why?
|
Atrophy | 1 | 2023 | 1633 | 0.040 |
Why?
|
Neuroaxonal Dystrophies | 1 | 2018 | 26 | 0.040 |
Why?
|
Apnea | 1 | 2000 | 195 | 0.040 |
Why?
|
Folate Receptor 1 | 1 | 2018 | 40 | 0.040 |
Why?
|
Ocular Motility Disorders | 1 | 2020 | 144 | 0.040 |
Why?
|
Polysomnography | 2 | 2002 | 1848 | 0.040 |
Why?
|
Oxidoreductases Acting on Sulfur Group Donors | 1 | 2018 | 32 | 0.040 |
Why?
|
Databases, Factual | 1 | 2014 | 7968 | 0.040 |
Why?
|
Bradycardia | 1 | 2000 | 299 | 0.040 |
Why?
|
Immunologic Factors | 1 | 2007 | 1590 | 0.040 |
Why?
|
Smoking | 1 | 2015 | 9053 | 0.040 |
Why?
|
Hemizygote | 1 | 2017 | 28 | 0.040 |
Why?
|
Tetrahydrofolates | 1 | 2018 | 58 | 0.040 |
Why?
|
Tissue Distribution | 1 | 2002 | 2264 | 0.040 |
Why?
|
Transgenes | 1 | 2021 | 1010 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 2 | 2017 | 17904 | 0.040 |
Why?
|
Coenzyme A Ligases | 1 | 2017 | 45 | 0.040 |
Why?
|
History, 20th Century | 1 | 2006 | 2767 | 0.040 |
Why?
|
DNA Mutational Analysis | 2 | 2019 | 4111 | 0.040 |
Why?
|
Neural Pathways | 1 | 2008 | 3060 | 0.040 |
Why?
|
Infant, Premature, Diseases | 2 | 2002 | 710 | 0.040 |
Why?
|
Prognosis | 2 | 2023 | 29629 | 0.040 |
Why?
|
Europe | 1 | 2024 | 3420 | 0.030 |
Why?
|
Proportional Hazards Models | 1 | 2011 | 12463 | 0.030 |
Why?
|
Neurites | 2 | 2010 | 391 | 0.030 |
Why?
|
Herpesvirus 4, Human | 1 | 2022 | 1078 | 0.030 |
Why?
|
Infant, Small for Gestational Age | 1 | 1999 | 461 | 0.030 |
Why?
|
Breast Neoplasms | 2 | 2012 | 21019 | 0.030 |
Why?
|
Mastectomy, Radical | 1 | 1996 | 19 | 0.030 |
Why?
|
Statistics, Nonparametric | 1 | 2002 | 2850 | 0.030 |
Why?
|
Cerebral Palsy | 2 | 2012 | 474 | 0.030 |
Why?
|
Moyamoya Disease | 1 | 1999 | 265 | 0.030 |
Why?
|
Parietal Lobe | 1 | 2021 | 852 | 0.030 |
Why?
|
Transcription Factors | 1 | 2015 | 12130 | 0.030 |
Why?
|
Gallbladder | 1 | 2017 | 308 | 0.030 |
Why?
|
Syndrome | 1 | 2002 | 3267 | 0.030 |
Why?
|
Parents | 2 | 2016 | 3563 | 0.030 |
Why?
|
Permeability | 1 | 2017 | 723 | 0.030 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2012 | 3514 | 0.030 |
Why?
|
Pregnancy | 3 | 2010 | 29890 | 0.030 |
Why?
|
Phosphoproteins | 1 | 2024 | 2448 | 0.030 |
Why?
|
Sequence Analysis, DNA | 2 | 2017 | 4740 | 0.030 |
Why?
|
Diagnostic Imaging | 1 | 2009 | 3530 | 0.030 |
Why?
|
Remote Sensing Technology | 1 | 2016 | 92 | 0.030 |
Why?
|
Thalamus | 1 | 2021 | 1047 | 0.030 |
Why?
|
G(M2) Ganglioside | 1 | 2014 | 15 | 0.030 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2006 | 2791 | 0.030 |
Why?
|
Counseling | 1 | 2002 | 1547 | 0.030 |
Why?
|
Asymptomatic Diseases | 1 | 2017 | 588 | 0.030 |
Why?
|
Anterior Thalamic Nuclei | 1 | 2014 | 27 | 0.030 |
Why?
|
Cell Membrane | 1 | 2023 | 3687 | 0.030 |
Why?
|
Respiration | 1 | 2000 | 1656 | 0.030 |
Why?
|
Pregnancy Complications | 2 | 2010 | 2947 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2009 | 20100 | 0.030 |
Why?
|
Genes, Recessive | 1 | 2015 | 623 | 0.030 |
Why?
|
Transcription, Genetic | 1 | 2007 | 7593 | 0.030 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2024 | 1469 | 0.030 |
Why?
|
Multiple Sclerosis | 1 | 2008 | 3222 | 0.030 |
Why?
|
Protein Structure, Secondary | 1 | 2015 | 1229 | 0.030 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2016 | 793 | 0.030 |
Why?
|
Glycine | 1 | 2015 | 663 | 0.030 |
Why?
|
Cell Line | 2 | 2021 | 15601 | 0.020 |
Why?
|
Anticonvulsants | 1 | 2022 | 1906 | 0.020 |
Why?
|
Antibodies, Neutralizing | 1 | 2021 | 1943 | 0.020 |
Why?
|
Pedigree | 1 | 2019 | 4542 | 0.020 |
Why?
|
Drug Administration Schedule | 2 | 1998 | 4853 | 0.020 |
Why?
|
Ultrasonography, Prenatal | 1 | 1999 | 1755 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2022 | 5247 | 0.020 |
Why?
|
Dopamine Agents | 1 | 2012 | 189 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2019 | 1902 | 0.020 |
Why?
|
Lymphocytes | 2 | 2010 | 2612 | 0.020 |
Why?
|
Magnetic Resonance Angiography | 1 | 2017 | 1432 | 0.020 |
Why?
|
Frontal Lobe | 1 | 2017 | 1420 | 0.020 |
Why?
|
Electroencephalography | 1 | 2006 | 6237 | 0.020 |
Why?
|
Fumonisins | 1 | 2010 | 10 | 0.020 |
Why?
|
Muscle Hypertonia | 1 | 2010 | 12 | 0.020 |
Why?
|
Clinical Protocols | 1 | 1996 | 1440 | 0.020 |
Why?
|
Remission Induction | 1 | 1996 | 2397 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2022 | 3060 | 0.020 |
Why?
|
Genotype | 1 | 2024 | 12990 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2018 | 1974 | 0.020 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2020 | 6019 | 0.020 |
Why?
|
Zebrafish | 1 | 2021 | 3008 | 0.020 |
Why?
|
United States | 3 | 2024 | 72340 | 0.020 |
Why?
|
Failure to Thrive | 1 | 2010 | 140 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2012 | 13642 | 0.020 |
Why?
|
Irritable Mood | 1 | 2010 | 194 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2015 | 3792 | 0.020 |
Why?
|
Nerve Tissue | 1 | 2008 | 78 | 0.020 |
Why?
|
Cytokines | 1 | 2023 | 7396 | 0.020 |
Why?
|
Heart Rate | 1 | 2000 | 4195 | 0.020 |
Why?
|
Proteins | 1 | 2023 | 6032 | 0.020 |
Why?
|
Neurotransmitter Agents | 1 | 2012 | 665 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2017 | 2735 | 0.020 |
Why?
|
Chick Embryo | 1 | 2010 | 982 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 2012 | 17635 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 2 | 2009 | 20568 | 0.020 |
Why?
|
Cognition | 2 | 2020 | 6992 | 0.020 |
Why?
|
JC Virus | 1 | 2008 | 87 | 0.020 |
Why?
|
Dementia, Vascular | 1 | 2008 | 122 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 2016 | 1664 | 0.020 |
Why?
|
RNA Probes | 1 | 2007 | 111 | 0.020 |
Why?
|
AIDS Dementia Complex | 1 | 2008 | 153 | 0.020 |
Why?
|
Methionine | 2 | 2005 | 572 | 0.020 |
Why?
|
Carcinoma | 1 | 1998 | 2330 | 0.020 |
Why?
|
Stereotaxic Techniques | 1 | 2009 | 555 | 0.020 |
Why?
|
Treatment Failure | 1 | 2012 | 2643 | 0.020 |
Why?
|
Models, Molecular | 1 | 2015 | 5439 | 0.020 |
Why?
|
Base Pairing | 1 | 2005 | 140 | 0.020 |
Why?
|
Ferric Compounds | 1 | 2007 | 378 | 0.020 |
Why?
|
Neurotoxicity Syndromes | 1 | 2009 | 301 | 0.010 |
Why?
|
Models, Anatomic | 1 | 2008 | 683 | 0.010 |
Why?
|
Child Development | 1 | 2016 | 2306 | 0.010 |
Why?
|
Sleep | 1 | 2020 | 4768 | 0.010 |
Why?
|
Cell Count | 1 | 2008 | 1835 | 0.010 |
Why?
|
Risk Factors | 3 | 2019 | 74213 | 0.010 |
Why?
|
Ovarian Neoplasms | 1 | 1998 | 4878 | 0.010 |
Why?
|
Nanotechnology | 1 | 2007 | 714 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 1996 | 11120 | 0.010 |
Why?
|
Sequence Deletion | 1 | 2005 | 1494 | 0.010 |
Why?
|
Base Sequence | 1 | 2012 | 12441 | 0.010 |
Why?
|
Cysteine | 1 | 2005 | 891 | 0.010 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2009 | 1841 | 0.010 |
Why?
|
Microelectrodes | 1 | 2000 | 306 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2009 | 2898 | 0.010 |
Why?
|
Platinum Compounds | 1 | 1998 | 95 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 1996 | 9280 | 0.010 |
Why?
|
False Positive Reactions | 1 | 2000 | 957 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2009 | 13446 | 0.010 |
Why?
|
Biopsy | 1 | 2009 | 6766 | 0.010 |
Why?
|
Protein Binding | 1 | 2009 | 9353 | 0.010 |
Why?
|
Incidence | 1 | 2015 | 21355 | 0.010 |
Why?
|
Inflammation | 1 | 1996 | 10774 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2009 | 4937 | 0.010 |
Why?
|
Antibiotics, Antineoplastic | 1 | 1998 | 678 | 0.010 |
Why?
|
Cerebral Infarction | 1 | 1999 | 983 | 0.010 |
Why?
|
Dementia | 1 | 2009 | 2689 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2008 | 11076 | 0.010 |
Why?
|
Models, Biological | 1 | 2010 | 9469 | 0.010 |
Why?
|
Substance-Related Disorders | 1 | 2010 | 4420 | 0.010 |
Why?
|
Monitoring, Intraoperative | 1 | 1999 | 942 | 0.010 |
Why?
|
Macrophages | 1 | 2008 | 5767 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2009 | 7859 | 0.010 |
Why?
|
Salvage Therapy | 1 | 1998 | 1263 | 0.010 |
Why?
|
Paclitaxel | 1 | 1998 | 1732 | 0.010 |
Why?
|
Melanoma | 1 | 2009 | 5709 | 0.010 |
Why?
|
Saccharomyces | 1 | 1969 | 63 | 0.000 |
Why?
|
Disease-Free Survival | 1 | 1998 | 6815 | 0.000 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2002 | 4016 | 0.000 |
Why?
|
Recurrence | 1 | 1998 | 8466 | 0.000 |
Why?
|
Molecular Biology | 1 | 1969 | 576 | 0.000 |
Why?
|
Sensitivity and Specificity | 1 | 2000 | 14665 | 0.000 |
Why?
|
Enzyme Repression | 1 | 1969 | 30 | 0.000 |
Why?
|
Transferases | 1 | 1969 | 72 | 0.000 |
Why?
|
Electrophoresis | 1 | 1969 | 227 | 0.000 |
Why?
|
Nucleosides | 1 | 1969 | 131 | 0.000 |
Why?
|
Ligases | 1 | 1969 | 333 | 0.000 |
Why?
|
Nucleotidyltransferases | 1 | 1969 | 244 | 0.000 |
Why?
|
Genes, Dominant | 1 | 1969 | 852 | 0.000 |
Why?
|
Homocysteine | 1 | 1969 | 638 | 0.000 |
Why?
|
Kinetics | 1 | 1969 | 6374 | 0.000 |
Why?
|